Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients

BACKGROUND: Gastric cancer relapse occurs in about 30% of the patients treated with gastrectomy and D2-lymphadenectomy, mainly as distant or peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been associated with an improvement in survival and lower peritoneal recurrence, a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Costa, Wilson L, Coimbra, Felipe J F, Ribeiro, Héber S C, Diniz, Alessandro L, de Godoy, André Luís, Begnami, MariaDirleiFS, Silva, Milton J B, Fanelli, Marcelo F, Mello, Celso A L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3495866/
https://ncbi.nlm.nih.gov/pubmed/22992263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-195
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak